Show simple item record

dc.contributor.authorGalindo-Villegas, Jorge
dc.date.accessioned2020-07-20T09:45:19Z
dc.date.available2020-07-20T09:45:19Z
dc.date.created2020-05-05T01:09:09Z
dc.date.issued2020
dc.identifier.citationGalindo-Villegas, J. (2020). The zebrafish disease and drug screening model: A strong ally against Covid-19. Frontiers in Pharmacology, 11: 680. doi:en_US
dc.identifier.issn1663-9812
dc.identifier.urihttps://hdl.handle.net/11250/2669697
dc.language.isoengen_US
dc.publisherFrontiersen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleThe zebrafish disease and drug screening model : A strong ally against Covid-19en_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2020 The Author(s)en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Farmakologi: 728en_US
dc.source.pagenumber2en_US
dc.source.volume11en_US
dc.source.journalFrontiers in Pharmacologyen_US
dc.identifier.doi10.3389/fphar.2020.00680
dc.identifier.cristin1809337
dc.description.localcodeUnit Licence Agreementen_US
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal